Bausch Health Companies (BHC) Assets (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Assets came in at $24.8 billion in Q2 2026, down 9.07% year-over-year from $27.3 billion in Q2 2025, and up 1.21% quarter-over-quarter from $24.5 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Assets (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Assets across 18 years of filings, most recently posting $24.8 billion for Q2 2026.
- In Q2 2026, Assets fell 9.07% year-over-year to $24.8 billion; the TTM figure through Jun 2026 stood at $24.8 billion (down 9.07% YoY), while the FY2025 annual figure was $26.4 billion, down 0.59% from the prior year.
- Assets came in at $24.8 billion for Q2 2026 at Bausch Health Companies, up from $24.5 billion in the prior quarter.
- In the past five years, Assets ranged from a high of $29.1 billion in Q1 2022 to a low of $24.5 billion in Q1 2026.
- Average Assets over 5 years is $26.5 billion, with a median of $26.5 billion recorded in 2024.
- The largest YoY upside for Assets was 6.48% in 2023 against a maximum downside of 12.53% in 2023.
- Over 5 years, Assets stood at $25.7 billion in 2022, then climbed by 6.48% to $27.4 billion in 2023, then slipped by 3.02% to $26.5 billion in 2024, then retreated by 0.59% to $26.4 billion in 2025, then dropped by 5.96% to $24.8 billion in 2026.
- Per Business Quant data, the three most recent Assets figures were $24.8 billion in Q2 2026, $24.5 billion in Q1 2026, and $26.4 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 39.86 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 35.04 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 6.08 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 3.78 Bn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 24.79 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 1.59 Bn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 1.49 Bn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 1.74 Bn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 75.75 Mn |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | 25.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.79 Bn |
| Mar 31, 2026 | 24.50 Bn |
| Dec 31, 2025 | 26.37 Bn |
| Sep 30, 2025 | 26.82 Bn |
| Jun 30, 2025 | 27.27 Bn |
| Mar 31, 2025 | 26.42 Bn |
| Dec 31, 2024 | 26.52 Bn |
| Sep 30, 2024 | 26.54 Bn |
| Jun 30, 2024 | 26.50 Bn |
| Mar 31, 2024 | 26.91 Bn |
| Dec 31, 2023 | 27.35 Bn |
| Sep 30, 2023 | 27.06 Bn |
| Jun 30, 2023 | 25.50 Bn |
| Mar 31, 2023 | 25.45 Bn |
| Dec 31, 2022 | 25.69 Bn |
| Sep 30, 2022 | 26.30 Bn |
| Jun 30, 2022 | 28.17 Bn |
| Mar 31, 2022 | 29.09 Bn |
| Dec 31, 2021 | 29.20 Bn |
| Sep 30, 2021 | 29.25 Bn |